DK2421852T3 - Heteroaromatiske og aromatiske piperazinylazetidinylamider som monoacylglycerollipaseinhibitor - Google Patents

Heteroaromatiske og aromatiske piperazinylazetidinylamider som monoacylglycerollipaseinhibitor

Info

Publication number
DK2421852T3
DK2421852T3 DK10719479.7T DK10719479T DK2421852T3 DK 2421852 T3 DK2421852 T3 DK 2421852T3 DK 10719479 T DK10719479 T DK 10719479T DK 2421852 T3 DK2421852 T3 DK 2421852T3
Authority
DK
Denmark
Prior art keywords
piperazinylazetidinylamides
monoacylgyleric
heteroaromatic
aromatic
lipase inhibitor
Prior art date
Application number
DK10719479.7T
Other languages
English (en)
Inventor
Kristen M Chevalier
Scott L Dax
Christopher M Flores
Li Liu
Mark J Macielag
Mark E Mcdonnell
Marina I Nelen
Matthew Todd
Sui-Po Zhang
Bin Zhu
Erica L Nulton
Jose Clemente
Stephen Prouty
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK2421852T3 publication Critical patent/DK2421852T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DK10719479.7T 2009-04-22 2010-04-22 Heteroaromatiske og aromatiske piperazinylazetidinylamider som monoacylglycerollipaseinhibitor DK2421852T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17166009P 2009-04-22 2009-04-22
PCT/US2010/032098 WO2010124121A1 (en) 2009-04-22 2010-04-22 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor

Publications (1)

Publication Number Publication Date
DK2421852T3 true DK2421852T3 (da) 2014-08-18

Family

ID=42224827

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10719479.7T DK2421852T3 (da) 2009-04-22 2010-04-22 Heteroaromatiske og aromatiske piperazinylazetidinylamider som monoacylglycerollipaseinhibitor

Country Status (17)

Country Link
US (1) US8815839B2 (da)
EP (1) EP2421852B9 (da)
JP (1) JP2012524809A (da)
KR (1) KR20120014154A (da)
CN (1) CN102548983B (da)
AR (1) AR076375A1 (da)
AU (1) AU2010238745A1 (da)
BR (1) BRPI1014888A2 (da)
CA (1) CA2759714A1 (da)
DK (1) DK2421852T3 (da)
ES (1) ES2486674T3 (da)
HK (2) HK1166794A1 (da)
IL (1) IL215796A (da)
PT (1) PT2421852E (da)
RU (1) RU2558141C2 (da)
TW (1) TWI495637B (da)
WO (1) WO2010124121A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2421848A1 (en) 2009-04-22 2012-02-29 Janssen Pharmaceutica N.V. Azetidinyl diamides as monoacylglycerol lipase inhibitors
AU2011296068B2 (en) 2010-09-03 2015-07-09 Janssen Pharmaceutica Nv Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
EP2621918A1 (en) 2010-09-27 2013-08-07 Janssen Pharmaceutica, N.V. Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
US8513423B2 (en) 2010-10-22 2013-08-20 Janssen Pharmaceutica, Nv Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
EP2630139A1 (en) 2010-10-22 2013-08-28 Janssen Pharmaceutica, N.V. Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
JP6454349B2 (ja) * 2013-12-26 2019-01-16 武田薬品工業株式会社 モノアシルグリセロールリパーゼ(magl)阻害剤としての4−(ピペラジン−1−イル)−ピロリジン−2−オン化合物
JP6616786B2 (ja) * 2014-05-19 2019-12-04 メリアル インコーポレイテッド 駆虫性化合物
WO2016158956A1 (ja) 2015-03-30 2016-10-06 武田薬品工業株式会社 複素環化合物
US11273167B2 (en) 2015-08-03 2022-03-15 The Regents Of The University Of California Compositions and methods for modulating ABHD2 activity
US10463753B2 (en) 2016-02-19 2019-11-05 Lundbeck La Jolla Research Center, Inc. Radiolabeled monoacylglycerol lipase occupancy probe
BR112018068538B1 (pt) 2016-03-31 2023-12-12 Takeda Pharmaceutical Company Limited Composto, medicamento, e, uso de um composto
WO2017170830A1 (ja) 2016-03-31 2017-10-05 武田薬品工業株式会社 複素環化合物
MX2020007318A (es) 2017-09-29 2020-08-24 Takeda Pharmaceuticals Co Compuesto heterociclico.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
US7435736B2 (en) * 2002-12-23 2008-10-14 Janssen Pharmaceutica, N.V. Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
EP1702916A1 (en) * 2005-03-18 2006-09-20 Santhera Pharmaceuticals (Schweiz) GmbH DPP-IV inhibitors
FR2915199B1 (fr) * 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
EP2283126A1 (en) * 2008-04-25 2011-02-16 Janssen Pharmaceutica, N.V. Crystal structure of monoacylglycerol lipase (mgll)
WO2009132260A1 (en) * 2008-04-25 2009-10-29 Janssen Pharmaceutica Nv Protein engineering of monoacylglycerol lipase (mgll)
EP2180048B1 (en) * 2008-10-09 2014-12-17 Janssen Pharmaceutica N.V. Alternative crystal form of monoacylglycerol lipase (MGLL)
US8435977B2 (en) * 2009-04-22 2013-05-07 Janssen Pharmaceutica, Nv Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors

Also Published As

Publication number Publication date
AU2010238745A1 (en) 2011-11-10
JP2012524809A (ja) 2012-10-18
ES2486674T3 (es) 2014-08-19
EP2421852B9 (en) 2015-07-01
TW201103917A (en) 2011-02-01
WO2010124121A1 (en) 2010-10-28
US8815839B2 (en) 2014-08-26
RU2011147203A (ru) 2013-05-27
AR076375A1 (es) 2011-06-08
HK1166794A1 (en) 2012-11-09
WO2010124121A8 (en) 2012-03-08
RU2558141C2 (ru) 2015-07-27
CN102548983B (zh) 2014-09-17
PT2421852E (pt) 2014-07-31
KR20120014154A (ko) 2012-02-16
EP2421852B1 (en) 2014-05-21
US20130184251A1 (en) 2013-07-18
CN102548983A (zh) 2012-07-04
HK1170239A1 (en) 2013-02-22
IL215796A (en) 2015-04-30
EP2421852A1 (en) 2012-02-29
IL215796A0 (en) 2012-01-31
TWI495637B (zh) 2015-08-11
CA2759714A1 (en) 2010-10-28
BRPI1014888A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
DK2421852T3 (da) Heteroaromatiske og aromatiske piperazinylazetidinylamider som monoacylglycerollipaseinhibitor
CY2020023I1 (el) Αναστολεiς βητα-λακταμασων
LTC2178888I2 (lt) Proteazomos inhibitoriai
DK2421825T3 (da) Azetidinyldiamider som monoacylglycerollipase-inhibitorer
DK2246336T3 (da) Fibroseinhibitor
DK3560498T3 (da) Kombination, der omfatter en mek-hæmmer og en b-raf-hæmmer
BRPI1009143A2 (pt) métodos e equipamentos para controlar a dureza da água
DK2432993T3 (da) En vindmølle og fremgangsmåde
EP2389068A4 (en) HEMGE OF THE HEDGEHOG SIGNAL PATH
BRPI0918564A2 (pt) inibidores
DK2639229T3 (da) Thiazolderivat og anvendelse deraf som VAP-1-hæmmer
SMP201000116B (it) Inibitori di diacetilasi B a base di idrossamato
DK2512451T3 (da) Modulator
EP2374802A4 (en) KYNURENIN PRODUCTION INHIBITOR
DK2510030T3 (da) Polyurethan-præpolymerer
DK2459528T3 (da) 2-(3-alkylthiobenzoyl) cyclohexandion og anvendelsen heraf som herbicider
DK2406372T3 (da) Prægastrisk esterase og derivater deraf
BRPI1014442A2 (pt) dispensador e método
DE102008016957A8 (de) Akkumulator-Ladevorrichtung
IL211811A0 (en) Protease inhibitors
ATE522533T1 (de) Pyrazolopyrimidinonkinaseinhibitor
BRPI0715729A2 (pt) inibidores para glyt-1
IT1393323B1 (it) Orologio da polso
GB0817425D0 (en) Protease inhibitors
TH110398B (th) ตัวยับยั้งฐานไฮดรอกซาเมตของดีอะเซทิเลส b